Zorzela L - Search Results

1

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.

Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. Among authors: zorzela l. J Clin Epidemiol. 2023 Jun;158:149-165. doi: 10.1016/j.jclinepi.2023.04.005. Epub 2023 Apr 24. J Clin Epidemiol. 2023. PMID: 37100738 Free article.

2

Children and spinal manipulation therapy: Ask your patients about all the therapies they seek.

Zorzela L, Vohra S. Zorzela L, et al. Paediatr Child Health. 2009 Jul;14(6):388. doi: 10.1093/pch/14.6.388. Paediatr Child Health. 2009. PMID: 20592975 Free PMC article. No abstract available.

3

Some improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011.

Golder S, Loke YK, Zorzela L. Golder S, et al. Among authors: zorzela l. J Clin Epidemiol. 2013 Mar;66(3):253-60. doi: 10.1016/j.jclinepi.2012.09.013. J Clin Epidemiol. 2013. PMID: 23347849

4

Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy.

Punja S, Zorzela L, Hartling L, Urichuk L, Vohra S. Punja S, et al. Among authors: zorzela l. BMJ Open. 2013 Mar 15;3(3):e002312. doi: 10.1136/bmjopen-2012-002312. BMJ Open. 2013. PMID: 23503579 Free PMC article.

5

Quality of reporting in systematic reviews of adverse events: systematic review.

Zorzela L, Golder S, Liu Y, Pilkington K, Hartling L, Joffe A, Loke Y, Vohra S. Zorzela L, et al. BMJ. 2014 Jan 8;348:f7668. doi: 10.1136/bmj.f7668. BMJ. 2014. PMID: 24401468 Free PMC article. Review.

6

Comparison of search strategies in systematic reviews of adverse effects to other systematic reviews.

Golder S, Loke YK, Zorzela L. Golder S, et al. Among authors: zorzela l. Health Info Libr J. 2014 Jun;31(2):92-105. doi: 10.1111/hir.12041. Epub 2014 Apr 23. Health Info Libr J. 2014. PMID: 24754741 Free article.

7

PRISMA harms checklist: improving harms reporting in systematic reviews.

Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher D, Vohra S; PRISMAHarms Group. Zorzela L, et al. BMJ. 2016 Feb 1;352:i157. doi: 10.1136/bmj.i157. BMJ. 2016. PMID: 26830668

8

Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

Junqueira DR, Zorzela LM, Perini E. Junqueira DR, et al. Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD007557. doi: 10.1002/14651858.CD007557.pub3. Cochrane Database Syst Rev. 2017. PMID: 28431186 Free PMC article. Review.

9

Is there a role for modified probiotics as beneficial microbes: a systematic review of the literature.

Zorzela L, Ardestani SK, McFarland LV, Vohra S. Zorzela L, et al. Benef Microbes. 2017 Oct 13;8(5):739-754. doi: 10.3920/BM2017.0032. Epub 2017 Sep 8. Benef Microbes. 2017. PMID: 28884589 Review.

10

Tool to assess causality of direct and indirect adverse events associated with therapeutic interventions.

Zorzela L, Mior S, Boon H, Gross A, Yager J, Carter R, Vohra S. Zorzela L, et al. Curr Med Res Opin. 2018 Mar;34(3):407-414. doi: 10.1080/03007995.2017.1383891. Epub 2017 Oct 24. Curr Med Res Opin. 2018. PMID: 28933962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page